"Investigación y Lectura de Señales Biomédicas, ILSB (www.signals.com) is a neurotechnology company, startup of the Polytechnical University of Madrid (UPM), founded in October 2016. Its main activity is the research, development and commercialization of its own technology for registration, processing and analysis of biomedical signals.
The project MemBoost, Memory Enhancing and Learning System, was awarded in 2015 by the business plan competition program, actúaupm, as one of the best business ideas proposed by researchers of the UPM. Since then, we have presented our project, as a technological company, in different forums in order to have economical resources for developing the project. In November 2018, we presented the project to the SME Phase I instrument, promoted by European Union, and a grant of 50,000 euros was proposed for exploring and assessing the technical feasibility and commercial potential of our breakthrough innovation.
MemBoost was born as a disruptive proposal for the enhancement of memory based on recent advances in neuroscience that place the relationship between sleep and memory at the center of academic debate. The general objective of MemBoost is to develop a wearable device for sleep modulation that significantly improves memory and learning.
MemBoost is a technology that improves the results of the study process, allowing the user to remember 22% more information with its use during sleep. Our implementation is based on a harmless electronic device (wearable consisting of hardware for recording the electrical signals of the brain and software for processing) for the enhancement of memory, which using sleep modulation techniques can improve the learning process. The operating principles and differential value of this technology has already been demonstrated by several research groups, pioneers in the field of neuroscience, published in internationally renowned scientific journals. [""Boosting slow oscillations during sleep potentiates memory"", Marshall et al, Nature (2006), p 210; ""Phase-locked loop for precisely timed acoustic stimulation during sleep"", Santostasi et al, Journal of neuroscience methods (2016), p 101-114].
The continued use of MemBoost may favor the maintenance of memories in very early stages of cognitive impairment helping in the treatment of neurodegenerative diseases such as Alzheimer.
The SME Instrument Phase I has as an overall objective of carry on studies or scientific or technological viability plan to determine if the available pre-existing results of Memboost allow to make the system a reality in a commercial way, determining the actions to be carried out to reach the market, economic feasibility studies that contribute to the realization of the business plan and the determination of the needs financial resources for its development, the elaboration of a commercialization plan that allows to identify the market niche and the needs of the system or clients and the regulatory and legal studies."
